Noveris Health Sciences Inc. (CSE:NVRS)
Canada · Delayed Price · Currency is CAD 2.600
+0.160 (6.56%)
At close: Jun 3, 2026
Noveris Health Sciences Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2.03 | 0.01 | 0 | 0.04 | 0.01 | 1.5 |
Short-Term Investments | - | - | - | - | 6.95 | - |
Cash & Short-Term Investments | 2.03 | 0.01 | 0 | 0.04 | 6.96 | 1.5 |
Cash Growth | 20576.58% | 2884.31% | -99.14% | -99.46% | 365.53% | -32.79% |
Other Receivables | - | - | 0.05 | 0.16 | 0.36 | 0.2 |
Receivables | - | - | 0.05 | 0.16 | 0.36 | 0.2 |
Prepaid Expenses | - | - | - | 0.02 | 1.22 | 3.52 |
Total Current Assets | 2.03 | 0.01 | 0.05 | 0.21 | 8.54 | 5.22 |
Property, Plant & Equipment | - | - | - | - | 0.01 | 0.57 |
Other Long-Term Assets | 0.02 | - | - | - | 0.68 | 1.79 |
Total Assets | 2.05 | 0.01 | 0.05 | 0.21 | 9.23 | 7.58 |
Accounts Payable | 1.95 | 1.92 | 2.78 | 4.16 | 3.83 | 0.45 |
Accrued Expenses | 0.53 | 0.54 | 5.67 | 2.55 | 1.51 | 0.93 |
Short-Term Debt | 0.14 | 0.13 | 0.24 | 0.21 | 0.09 | - |
Current Portion of Long-Term Debt | 0.29 | 9.31 | 6.63 | 5.21 | - | - |
Current Portion of Leases | - | - | - | - | - | 0.08 |
Other Current Liabilities | 1.41 | 0.36 | - | - | 0.4 | 1.49 |
Total Current Liabilities | 4.31 | 12.26 | 15.33 | 12.13 | 5.82 | 2.95 |
Long-Term Debt | - | 0.14 | - | - | 4.7 | 4.35 |
Long-Term Leases | - | - | - | - | - | 0.07 |
Other Long-Term Liabilities | - | 0.08 | - | - | - | - |
Total Liabilities | 4.31 | 12.48 | 15.33 | 12.13 | 10.52 | 7.37 |
Common Stock | 138.1 | 126.27 | 126.27 | 126.12 | 115.92 | 107.66 |
Additional Paid-In Capital | 16.12 | 16.12 | 16.79 | 16.79 | 16.79 | 17.29 |
Retained Earnings | -156.47 | -154.86 | -158.63 | -155.11 | -134.16 | -124.92 |
Comprehensive Income & Other | - | - | 0.29 | 0.29 | 0.18 | 0.18 |
Shareholders' Equity | -2.25 | -12.47 | -15.28 | -11.92 | -1.28 | 0.21 |
Total Liabilities & Equity | 2.05 | 0.01 | 0.05 | 0.21 | 9.23 | 7.58 |
Total Debt | 0.42 | 9.58 | 6.87 | 5.42 | 4.78 | 4.5 |
Net Cash (Debt) | 1.61 | -9.57 | -6.87 | -5.39 | 2.18 | -3.01 |
Net Cash Per Share | 0.33 | -7.75 | -5.76 | -8.77 | 12.60 | -32.11 |
Filing Date Shares Outstanding | 58.55 | 58.55 | 1.24 | 1.24 | 0.43 | 0.1 |
Total Common Shares Outstanding | 58.55 | 1.24 | 1.24 | 1.05 | 0.3 | 0.1 |
Working Capital | -2.27 | -12.25 | -15.28 | -11.92 | 2.73 | 2.27 |
Book Value Per Share | -0.04 | -10.10 | -12.37 | -11.33 | -4.31 | 2.02 |
Tangible Book Value | -2.25 | -12.47 | -15.28 | -11.92 | -1.28 | 0.21 |
Tangible Book Value Per Share | -0.04 | -10.10 | -12.37 | -11.33 | -4.31 | 2.02 |
Machinery | - | - | - | - | 0.02 | 0.36 |
Leasehold Improvements | - | - | - | - | - | 0.23 |